Literature DB >> 23780403

Leptin concentration and nutritional status in the course of treatment in children with brain tumours--preliminary report.

Katarzyna Musiol1, Grazyna Sobol, Agnieszka Mizia-Malarz, Halina Wos.   

Abstract

PURPOSE: To assess the nutritional status in children with central nervous system (CNS) tumours, including concentration of leptin, the neuropeptide responsible for regulation of energetic homeostasis in an organism.
METHOD: The studied group comprised 44 children with brain tumours, aged (4.02-18.7). In all children during the whole therapy (from the start to the period of 1 year and more after the end of therapy), a number of standard deviations (SDs) for the body mass index (SDS BMI) was derived from anthropometric measurements. Concentrations of leptin were assayed simultaneously. RESULT: The lowest values of the anthropometric indices were found in children during the maintenance therapy. Concentrations of leptin in patients with malignant CNS tumours and significant undernutrition were slightly greater as compared to patients presenting normal nutritional status; however, without statistical significance.
CONCLUSION: In children with tumours of the central nervous system, there are quantitative disorders of the nutritional status which correlate with the period of the treatment. The most significant disorders in the nutritional status are observed during maintenance chemotherapy. There was no statistically significant correlation between the concentration of leptin and nutritional status in children with malignant brain tumours during the course of treatment and after its completion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23780403     DOI: 10.1007/s00381-013-2183-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  22 in total

Review 1.  The causes and consequences of cancer-associated malnutrition.

Authors:  Eric Van Cutsem; Jann Arends
Journal:  Eur J Oncol Nurs       Date:  2005       Impact factor: 2.398

2.  Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood.

Authors:  N H Birkebaek; S Fisker; N Clausen; V Tuovinen; S Sindet-Pedersen; J S Christiansen
Journal:  Med Pediatr Oncol       Date:  1998-06

3.  Malnutrition in children with cancer: incidence and consequence.

Authors:  J van Eys
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

4.  Leptin and the regulation of body weigh.

Authors:  Jeffrey M Friedman
Journal:  Keio J Med       Date:  2011

Review 5.  Hospital malnutrition: prevalence, identification and impact on patients and the healthcare system.

Authors:  Lisa A Barker; Belinda S Gout; Timothy C Crowe
Journal:  Int J Environ Res Public Health       Date:  2011-02-16       Impact factor: 3.390

Review 6.  The adipocyte as an active participant in energy balance and metabolism.

Authors:  Michael K Badman; Jeffrey S Flier
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

7.  Human leptin induces angiogenesis in vivo.

Authors:  Stavros Anagnostoulis; Anastasios J Karayiannakis; Maria Lambropoulou; Anna Efthimiadou; Alexandros Polychronidis; Constantinos Simopoulos
Journal:  Cytokine       Date:  2008-04-29       Impact factor: 3.861

Review 8.  Catabolic mediators of cancer cachexia.

Authors:  Michael J Tisdale
Journal:  Curr Opin Support Palliat Care       Date:  2008-12       Impact factor: 2.302

Review 9.  Leptin receptor action and mechanisms of leptin resistance.

Authors:  H Münzberg; M Björnholm; S H Bates; M G Myers
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

Review 10.  Leptin: structure, function and biology.

Authors:  Faming Zhang; Yanyun Chen; Mark Heiman; Richard Dimarchi
Journal:  Vitam Horm       Date:  2005       Impact factor: 3.421

View more
  1 in total

Review 1.  The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer.

Authors:  Magdalena Schab; Szymon Skoczen
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.